Aug-19
AUTHORS : Dr Rachel E. Sobel, Epidemiology/Worldwide Research and Development, Pfizer Inc, 235 East 42nd St. MS# 219-9-1, New York, NY, 10017, USA – Email: rachel.sobel@pfizer.com
JOURNAL : Pharmacoepidemiology and Drug Safety
REFERENCE: 28(S2):264
DOI : 10.1002/pds.4864